Skip to main content
Clinical Trials/NCT06294249
NCT06294249
Completed
Phase 4

The Evaluation of Pain Severity in Flapless Dental Implant Placement Using Laser-induced Incisions: A Split Mouth Randomized Clinical Trial Study

Shiraz University of Medical Sciences1 site in 1 country40 target enrollmentJanuary 1, 2020

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Jaw, Edentulous, Partially
Sponsor
Shiraz University of Medical Sciences
Enrollment
40
Locations
1
Primary Endpoint
Pain Severity
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

The goal of this split-mouth randomized clinical trial study was to investigate the effect of using a laser on pain and discomfort following flapless dental implant surgery. It was hypothesized that laser did not have any impact on post-op pain. Therefore, the study aimed to compare pain and discomfort following flapless dental implant surgeries with or without a laser.

Registry
clinicaltrials.gov
Start Date
January 1, 2020
End Date
December 4, 2023
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Reza Tabrizi, DMD

Associate Professor of Oral and Maxillofacial Surgery

Shiraz University of Medical Sciences

Eligibility Criteria

Inclusion Criteria

  • Adult human subjects agreed to participate in the study and return on follow-up times
  • Subjects eligible for receiving dental implants
  • Subjects with an edentulous area in the posterior of the mandible bilaterally 3- Subjects with sufficient bone width and height (\>5 mm width, and \>10 mm height) at the implant sites
  • Subjects with sufficient keratinization tissue at the implant sites

Exclusion Criteria

  • Subjects refused to return for follow-up or refused study enrollment.
  • Subjects with uncontrolled systemic diseases
  • Subjects younger than 18 years
  • Subjects receiving psychotropic drugs

Outcomes

Primary Outcomes

Pain Severity

Time Frame: Patients were visited at 24, 48, 72 hours, and 7 days after insertion.

Measured using the visual analogue scale (VAS): 0-3 mild pain, 4-6 moderate pain, and 7-10 sever pain.

Study Sites (1)

Loading locations...

Similar Trials